United States:
New Laws Extend IVIG Demonstration and Expiring Public Health Programs, Promote Early Hearing Detection and Intervention
30 October 2017
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
President Trump has signed into law a bill (P.L. 115-63) that extends the Medicare Intravenous Immune Globulin (IVIG)
Demonstration through December 31, 2020. The law also extends
through the first quarter of FY2018 (1) the Teaching Health Center
Graduate Medical Education Program, and (2) the Special Diabetes
Program for Indians.
The President also signed S 652, the Early Hearing Detection and
Intervention Act of 2017. The new law reauthorizes and modifies HHS
programs for early detection, diagnosis, and treatment regarding
deaf and hard-of-hearing newborns, infants, and young children.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...